Related references
Note: Only part of the references are listed.Quantification of the HIV-1 total reservoir in the peripheral blood of naive and treated patients by a standardised method derived from a commercial HIV-1 RNA quantification assay
Laura Di Sante et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1
Alessia Bertoldi et al.
JOURNAL OF VIROLOGICAL METHODS (2020)
HIV treatment and prevention 2019: current standards of care
Nittaya Phanuphak et al.
CURRENT OPINION IN HIV AND AIDS (2020)
Measuring the Success of HIV-1 Cure Strategies
Jordan Thomas et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART
Nadine Bachmann et al.
NATURE COMMUNICATIONS (2019)
Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success
Claudia Alteri et al.
JOURNAL OF CLINICAL VIROLOGY (2019)
New Frontiers in Measuring and Characterizing the HIV Reservoir
Shane D. Falcinelli et al.
FRONTIERS IN MICROBIOLOGY (2019)
Predictors of virological failure in HIV-1-infected patients switching to dolutegravir maintenance monotherapy
I. E. A. Wijting et al.
HIV MEDICINE (2019)
Novel Latency Reversal Agents for HIV-1 Cure
Adam M. Spivak et al.
ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)
Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood
Ilaria Vicenti et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Digital PCR as a tool to measure HIV persistence
Sofie Rutsaert et al.
RETROVIROLOGY (2018)
Measuring replication competent HIV-1: advances and challenges in defining the latent reservoir
Zheng Wang et al.
RETROVIROLOGY (2018)
Interlaboratory quality control of total HIV-1 DNA load measurement for multicenter reservoir studies
Pierre Gantner et al.
JOURNAL OF MEDICAL VIROLOGY (2017)
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns
Francesca Falasca et al.
BMC INFECTIOUS DISEASES (2017)
HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells
Chi N. Chan et al.
RETROVIROLOGY (2016)
Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal
Mateusz Stoszko et al.
EBIOMEDICINE (2016)
Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory Agents
Heloise M. Delagreverie et al.
OPEN FORUM INFECTIOUS DISEASES (2016)
A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control
Lambert Assoumou et al.
AIDS (2015)
Towards an HIV-1 cure: measuring the latent reservoir
Katherine M. Bruner et al.
TRENDS IN MICROBIOLOGY (2015)
T-cell activation positively correlates with cell-associated HIV-DNA level in viremic patients with primary or chronic HIV-1 infection
Laurence Weiss et al.
AIDS (2014)
Quantification of Integrated HIV DNA by Repetitive-Sampling Alu-HIV PCR on the Basis of Poisson Statistics
Ward De Spiegelaere et al.
CLINICAL CHEMISTRY (2014)
Low copy target detection by Droplet Digital PCR through application of a novel open access bioinformatic pipeline, 'definetherain'
Mathew Jones et al.
JOURNAL OF VIROLOGICAL METHODS (2014)
HIV-1 DNA predicts disease progression and post-treatment virological control.
James P. Williams et al.
ELIFE (2014)
Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure
Ya-Chi Ho et al.
CELL (2013)
Dynamics of Cellular HIV-1 DNA Levels Over 144 Weeks of Darunavir/Ritonavir Monotherapy Versus Triple Therapy in the MONET Trial
Anna Maria Geretti et al.
HIV CLINICAL TRIALS (2013)
Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies
Susanne Eriksson et al.
PLOS PATHOGENS (2013)
Impact of HIV Type 1 DNA Levels on Spontaneous Disease Progression: A Meta-Analysis
Chrissa G. Tsiara et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2012)
Factors Associated With Virological Failure in HIV-1-Infected Patients Receiving Darunavir/Ritonavir Monotherapy
Sidonie Lambert-Niclot et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
A High HIV DNA Level in PBMCs at Antiretroviral Treatment Interruption Predicts a Shorter Time to Treatment Resumption, Independently of the CD4 Nadir
Christophe Piketty et al.
JOURNAL OF MEDICAL VIROLOGY (2010)
LTR Real-Time PCR for HIV-1 DNA Quantitation in Blood Cells for Early Diagnosis in Infants Born to Seropositive Mothers Treated in HAART Area (ANRS CO 01)
Veronique Avettand-Fenol et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
HIV DNA and cognition in a Thai longitudinal HAART initiation cohort The SEARCH 001 Cohort Study
V. G. Valcour et al.
NEUROLOGY (2009)
Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level
JP Viard et al.
AIDS (2004)
Predictors of plasma human immunodeficiency virus type 1 RNA control after discontinuation of highly active antiretroviral therapy initiated at acute infection combined with structured treatment interruptions and immune-based therapies
A Lafeuillade et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
ME Sharkey et al.
NATURE MEDICINE (2000)
Share Paper
